Sabby Management, LLC Aditxt, Inc. Transaction History

Sabby Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.13 - $0.46 $75,104 - $265,754	-577,727 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.34 - $0.58 $220,861 - $376,763	-649,593 Reduced 52.93%	577,727 $264,000
Q4 2021 Feb 14, 2022	BUY	$0.54 - $2.51 $596,406 - $2.77 Million	1,104,457 Added 898.93%	1,227,320 $658,000
Q3 2021 Nov 15, 2021	SELL	$1.54 - $3.04 $96,151 - $189,805	-62,436 Reduced 33.69%	122,863 $208,000
Q2 2021 Aug 16, 2021	BUY	$2.2 - $3.2 $41,659 - $60,595	18,936 Added 11.38%	185,299 $480,000
Q1 2021 May 17, 2021	BUY	$2.08 - $5.26 $346,035 - $875,069	166,363 New	166,363 $424,000
Q4 2020 Feb 16, 2021	SELL	$1.89 - $2.48 $425,195 - $557,928	-224,971 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.7 - $7.6 $382,450 - $1.71 Million	224,971 New	224,971 $439,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $1.37M
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.